Dexamethasone rapidly suppresses IL-33-stimulated mast cell function by blocking transcription factor activity
Open Access
- 21 July 2016
- journal article
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 100 (6) , 1395-1404
Abstract
Mast cells are critical effectors of allergic disease and can be activated by IL-33, a proinflammatory member of the IL-1 cytokine family. IL-33 worsens the pathology of mast cell–mediated diseases, but therapies to antagonize IL-33 are still forthcoming. Because steroids are the mainstay of allergic disease treatment and are well known to suppress mast cell activation by other stimuli, we examined the effects of the steroid dexamethasone on IL-33-mediated mast cell function. We found that dexamethasone potently and rapidly suppressed cytokine production elicited by IL-33 from murine bone marrow–derived and peritoneal mast cells. IL-33 enhances IgE-mediated mast cell cytokine production, an activity that was also antagonized by dexamethasone. These effects were consistent in human mast cells. We additionally observed that IL-33 augmented migration of IgE-sensitized mast cells toward antigen. This enhancing effect was similarly reversed by dexamethasone. Simultaneous addition of dexamethasone with IL-33 had no effect on the phosphorylation of MAP kinases or NFκB p65 subunit; however, dexamethasone antagonized AP-1- and NFκB-mediated transcriptional activity. Intraperitoneal administration of dexamethasone completely abrogated IL-33-mediated peritoneal neutrophil recruitment and prevented plasma IL-6 elevation. These data demonstrate that steroid therapy may be an effective means of antagonizing the effects of IL-33 on mast cells in vitro and in vivo, acting partly by suppressing IL-33-induced NFκB and AP-1 activity.Keywords
Funding Information
- U.S. National Institutes of Health
- National Institute of Allergy and Infectious Diseases (1R01AI101153, 2R01AI059638, 1R01 AI095494)
This publication has 49 references indexed in Scilit:
- IL-33, but Not IL-25, Is Crucial for the Development of House Dust Mite Antigen-Induced Allergic RhinitisPLOS ONE, 2013
- Intraperitoneal influx of neutrophils in response to IL-33 is mast cell–dependentBlood, 2013
- IL‐33 induces skin inflammation with mast cell and neutrophil activationEuropean Journal of Immunology, 2011
- Amplification of cytokine production through synergistic activation of NFAT and AP‐1 following stimulation of mast cells with antigen and IL‐33European Journal of Immunology, 2011
- Role of IL-33 in inflammation and diseaseJournal of Inflammation, 2011
- IL-33 Is Produced by Mast Cells and Regulates IgE-Dependent InflammationPLOS ONE, 2010
- FcεRI-mediated mast cell migration: Signaling pathways and dependence on cytosolic free Ca2+ concentrationCellular Signalling, 2009
- Mast cells mediate neutrophil recruitment and vascular leakage through the NLRP3 inflammasome in histamine-independent urticariaJournal of Experimental Medicine, 2009
- IL-33 exacerbates antigen-induced arthritis by activating mast cellsProceedings of the National Academy of Sciences, 2008
- IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factorin vivoProceedings of the National Academy of Sciences, 2007